Shanghai Haohai Biological Technology 2024 Annual Report: The proportion of medical aesthetics business has further increased, and the impact of policies such as centralized procurement has not yet faded.

① The medical beauty Sector achieved revenue of 1.195 billion yuan, a year-on-year increase of 13.08%, with the business proportion rising from 39.96% to 44.38%, becoming the core driving force behind the company's current performance growth. ② Compared to the "counter-trend growth" of the medical beauty Sector, multiple sectors of Shanghai Haohai Biological Technology experienced varying degrees of revenue decline, and have not yet overcome the painful adjustment period of policies.

cls.cnMar 22 03:10 ET

Haohai Biotech: Summary of the 2024 Annual Report of Shanghai Haohai Biotechnology Co., Ltd.

SZSIMar 21 12:00 ET · Announcements

Haohai Biotech: Shanghai Haohai Biotechnology Co., Ltd. 2024 Annual Report

SZSIMar 21 12:00 ET · Announcements

Summary of the 2024 Annual Report of Shanghai Haohai Biotechnology Co., Ltd.

SZSIMar 21 12:00 ET · Announcements

Shanghai Haohai Biotechnology Co., Ltd. 2024 Annual Report

SZSIMar 21 12:00 ET · Announcements

HAOHAI BIOTEC (06826) intends to re-appoint Ernst & Young Hua Ming Accounting Firm.

HAOHAI BIOTEC (06826) announced that the company intends to reappoint Ernst & Young Hua Ming Accounting Firm (special general partnership)...

Zhitong FinanceMar 21 09:35 ET